J. Enzing

Do economic evaluations of TAVI deal with learning effects, innovation, and context dependency? A review

W. Brouwer, S. Knies, B. Boer, 2020 .

Broadening the application of health technology assessment in the Netherlands: a worthwhile destination but not an easy ride?

W. Brouwer, S. Knies, B. Boer, 2020, Health Economics, Policy and Law.

Review: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.

W. Goettsch, J. Enzing, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Psychometric evaluation of the Mental Health Quality of Life (MHQoL) instrument in seven European countries

A. Torbica, W. Brouwer, J. van Exel, 2022, Health and Quality of Life Outcomes.

Do Health Technology Assessment organisations consider manufacturers’ costs in relation to drug price? A study of reimbursement reports

Maarten J. IJzerman, B. Sander, W. Brouwer, 2022, Cost Effectiveness and Resource Allocation.

Do Profit Margins of Pharmaceuticals Influence Reimbursement Decisions? A Discrete Choice Experiment Among Dutch Healthcare Decision Makers.

W. Brouwer, S. Himmler, S. Knies, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.